Abstract
The present work is devoted to the study of the reactivity of tetrahydropyrrolo[1,2-b]isothiazol-3(2H)-one 1,1-dioxide framework. This scaffold possesses two reaction centers: the EWG-activated methylene group and the carbonyl functionality, which are the basic variation points. At the same time, the attached 3a-substituent had a significant impact on the course of the explored reactions and its role was also investigated. In this regard, the corresponding 3a-unsubstituted and 3a-methylated tetrahydropyrrolo[1,2-b]isothiazol-3(2H)-one 1,1-dioxides were chosen as model substances involved in chemical properties evaluation. With a view to pre-assess the activity of the model compounds, a deuteration study was conducted. Furthermore, the interaction with a variety of electrophilic and nucleophilic agents was explored. The most striking difference in the chemical behavior was observed in the reaction with the Wittig reagent triphenylcarbethoxymethylenephosphorane (Ph3P=CHCO2Me). In particular, unlike the 3a-unsubstituted substrate, the 3a-methylated one gave the unusual phosphonium betaine, namely 3a-methyl-2-[2-(triphenylphosphonio)acetyl]-3a,4,5,6-tetrahydropyrrolo[1,2-b]isothiazol-3-olate 1,1-dioxide. The proposed mechanistic insights of this reaction have been discovered.
Graphic abstract
Similar content being viewed by others
References
Brameld KA, Kuhn B, Reuter DC, Stahl M (2008) J Chem Inf Model 48:1
Yoshino H, Ueda N, Niijima J, Sugumi H, Kotake Y, Koyanagi N, Yoshimatsu K, Asada M, Watanabe T, Nagasu T, Tsukahara K, Iijima A, Kitoh K (1992) J Med Chem 35:2496
Apaydın S, Török M (2019) Bioorg Med Chem Lett 29:2042
Shah SS, Rivera G, Ashfaq M (2013) Mini Rev Med Chem 13:70
Grygorenko OO, Volochnyuk DM, Ryabukhin SV, Judd DB (2020) Chem Eur J 26:1196
Grygorenko OO, Biitseva AV, Zhersh S (2018) Tetrahedron 74:1355
Koeplinger KA, Zhao Z, Peterson T, Leone JW, Schwende FS, Heinrikson RL, Tomasselli AG (1999) Drug Metab Dispos 27:986
(2007) Prontosil. In: Lesch JE (eds) The First miracle drugs: how the sulfa drugs transformed medicine. Oxford University Press, New York, p 51
Raju TNK (1999) Lancet 353:681
Cooper GF (1991) Synthesis 1991:859
Lad N, Sharma R, Marquez VE, Mascarenhas M (2013) Tetrahedron Lett 54:6307
Popova MV, Dobrydnev AV (2017) Chem Heterocycl Compd 53:492
Majumdar KC, Mondal S (2011) Chem Rev 111:7749
Debnath S, Mondal S (2018) Eur J Org Chem 2018:933
Rassadin VA, Grosheva DS, Tomashevskii AA, Sokolov VV (2013) Chem Heterocycl Comp 49:39
Mondal S, Debnath S (2014) Synthesis 46:368
Rabasseda X, Hopkins SJ (1994) Drugs Today 30:557
Lombardino JG, Wiseman EH, McLamore WM (1971) J Med Chem 14:1171
Tanimukai H, Inui M, Harigushi S, Kaneko J (1965) Biochem Pharmacol 14:961
Kasper S, McEwen BS (2008) CNS Drugs 22:15
Stachel H-D, Drasch G, Kunze J, Peh J (1976) β-Ketopropansultones and -sultams. DE Patent 2,431,734, Jan 29, 1976; (1976) Chem Abstr 84:135626
Stachel H-D, Drasch G (1985) Arch Pharm 318:304
Stachel H-D, Poschenrieder H, Lomitzky V (1992) Arch Pharm 325:461
Schobert R, Schlenk A (2008) Bioorg Med Chem 16:4203
Tuske S, Sarafianos SG, Wang X, Hudson BB, Sineva E, Mukhopadhyay J, Birktoft JJ, Leroy O, Ismail S, Clark AD Jr, Dharia C, Napoli A, Laptenko O, Lee J, Borukhov S, Ebright RH, Arnold E (2005) Cell 122:541
Aoki S, Higuchi K, Ye Y, Satari R, Kobayashi M (2000) Tetrahedron 56:1833
Phillips NJ, Goodwin JT, Fraiman A, Cole RJ, Lynn DG (1989) J Am Chem Soc 111:8223
Marfori EC, Kajiyama S, Fukusaki E-I, Kobayashi A (2002) Z Naturforsch C 57:465
Höltzel A, Gänzle MG, Nicholson GJ, Hammes WP, Jung G (2000) Angew Chem 112:2886 ((2000) Angew Chem Int Ed 39:2766)
Marquardt U, Schmid D, Jung G (2000) Synlett 8:1131
Athanasellis G, Igglessi-Markopoulou O, Markopoulos J (2010) Bioinorg Chem Appl 2010:315056
Brück E, Elbert A, Fischer R, Krueger S, Kühnhold J, Klueken AM, Nauen R, Niebes J-F, Reckmann U, Schnorbach H-J, Steffens R, van Waetermeulen X (2009) Crop Prot 28:838
Van Nhien AN, Tomassi C, Len C, Marco-Contelles JL, Balzarini J, Pannecouque C, De Clercq E, Postel D (2005) J Med Chem 48:4276
Baumann K (2007) Pharmaceutically active tetrahydropyrrolo[1,2-b]isothiazole 1,1-dioxides. WO Patent 2007,039,616, Apr 12, 2007; (2007) Chem Abstr 146:421974
Marco JL, Ingate ST, Chinchón PM (1999) Tetrahedron 55:7625
Postel D, Nguyen A, Nhien V, Marco JL (2003) Eur J Org Chem 2003:3713
Marco JL, Ingate ST, Jaime C, Beá I (2000) Tetrahedron 56:2523
Dobrydnev AV, Popova MV, Saffon-Merceron N, Listunov D, Volovenko YM (2015) Synthesis 47:2523
Popova MV, Dobrydnev AV, Dyakonenko VV, Konovalova IS, Shishkina SV, Volovenko YM (2019) Tetrahedron 75:1231
Omelian TV, Dobrydnev AV, Ostapchuk EN, Volovenko YM (2019) Chem Select 4:4933
Popova MV, Dobrydnev AV, Dyachenko, Duhayon C, Listunov D, Volovenko YM (2017) Monatsh Chem 148:939
Dobrydnev AV, Vashchenko BV, Konovalova IS, Bisikalo KO, Volovenko YM (2018) Monatsh Chem 149:1827
Dyachenko, Dobrydnev AV, Volovenko YM (2018) Mol Div 22:919
Hur MY (2015) Synthesis of novel sultam scaffolds: method and library development. Ph.D. thesis, University of Kansas, USA
Thomsen MW, Handwerker BM, Katz SA, Fisher SA (1988) Synth Commun 18:1433
Singh BK, Bisht SS, Tripathi RP (2006) Beilstein J Org Chem 2006(2):24
Aliev ZG, Maslivets AN, Simonchik OL, Konyukhova TG, Andreichikov YS, Atovmyan LO (1995) Russ Chem Bull 44:1496
Tomilov YV, Platonov DN, Dorokhov DV, Nefedov OM (2007) Tetrahedron Lett 48:883
Schobert R (2005) Org Synth 82:140
Bartlett M (2013) Synlett 24:773
Schlenk A, Diestel R, Sasse F, Schobert R (2010) Chem Eur J 16:2599
Schobert R, Siegfried S, Nieuwenhuyzen M, Milius W, Hampel F (2000) J Chem Soc Perkin Trans 1(11):1723
Abu-Shanab FA, Sherif MS, Mousaa S (2009) J Heterocycl Chem 46:801
Brahma S, Ray JK (2008) Tetrahedron 64:2883
Stanovnik B, Svete J (2004) Chem Rev 104:2433
Tkachuk TM, Shyshkina OO, Volovnenko TA, Volovenko YM, Zubatyuk RI, Medviediev VV, Shishkin OV (2013) Monatsh Chem 144:263
Perrin DD, Armarego IF, Perrin DR (1980) Purification of laboratory chemicals, 2nd edn. Pergamon Press, New York
Sheldrick G (2008) Acta Crystallogr Sect A 64:112
Acknowledgements
The work was funded by Enamine Ltd. A.V.D. was also funded by the Ministry of Education and Science of Ukraine (Grant No. 19БФ037-03). We thank Iryna Omelian for assistance with methodology, Svitlana Omelian for a fellowship and comments that greatly improved the manuscript, and Vitaliy Polovinko for providing the NMR experiments. The authors also show their gratitude to Prof. Andrey A. Tolmachev for his encouragement and support.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Omelian, T.V., Dobrydnev, A.V., Utchenko, O.Y. et al. The reactivity of tetrahydropyrrolo[1,2-b]isothiazol-3(2H)-one 1,1-dioxides. Monatsh Chem 151, 1759–1772 (2020). https://doi.org/10.1007/s00706-020-02694-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-020-02694-3